Dear Forum members,
I have a question regarding SSP and IFU. For our IVD (class C) we have prepared an SSP and shared with the NB that has accepted/validated the document. However, according to IVDR requirements labelling and/or IFU shall indicate where in EUDAMED the SSP can be found.
For class C and D devices, other than devices for performance studies, the manufacturer shall draw up a summary of safety and performance.The summary of safety and performance shall be written in a way that is clear to the intended user and, if relevant, to the patient and shall be made available to the public via Eudamed.The draft of the summary of safety and performance shall be part of the documentation to be submitted to the notified body involved in the conformity assessment pursuant to Article 48 and shall be validated by that body. After its validation, the notified body shall upload the summary to Eudamed. The manufacturer shall mention on the label or instructions for use where the summary is available.We have not yet registered the company in EUDAMED, so how shall such a statement be written in the mean time?
Could we make it available on our company website and reference this location or must it absolutely be EUDAMED?
Could we say in the IFU:
"The SSP will be made available in EUDAMED as soon it's fully functional". or
"The SSP is available under at
www.XYZ.com/SSP".Do you have any insights, how the EUDAMED location has to be defined/identified?
Thanks in advance for your help.
Enrico
------------------------------
Le Mont-sur-Lausanne
Switzerland
------------------------------